These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27558603)

  • 41. Generation of iPS cells using a BacMam multigene expression system.
    Takata Y; Kishine H; Sone T; Andoh T; Nozaki M; Poderycki M; Chesnut JD; Imamoto F
    Cell Struct Funct; 2011; 36(2):209-22. PubMed ID: 21979235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.
    Sivapatham R; Zeng X
    Methods Mol Biol; 2016; 1353():25-44. PubMed ID: 25520284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of Induced Pluripotent Stem Cells in Rabbits.
    Afanassieff M; Tapponnier Y; Savatier P
    Methods Mol Biol; 2016; 1357():149-72. PubMed ID: 25413017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viable mice produced from three-factor induced pluripotent stem (iPS) cells through tetraploid complementation.
    Kang L; Wu T; Tao Y; Yuan Y; He J; Zhang Y; Luo T; Kou Z; Gao S
    Cell Res; 2011 Mar; 21(3):546-9. PubMed ID: 21119684
    [No Abstract]   [Full Text] [Related]  

  • 45. Induced pluripotent stem cells expressing elevated levels of sox-2, oct-4, and klf-4 are severely reduced in their differentiation from mesodermal to hematopoietic progenitor cells.
    Seiler K; Soroush Noghabi M; Karjalainen K; Hummel M; Melchers F; Tsuneto M
    Stem Cells Dev; 2011 Jul; 20(7):1131-42. PubMed ID: 21348597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.
    Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M
    Science; 2016 Nov; 354(6315):. PubMed ID: 27884981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Artificial acceleration of mammalian cell reprogramming by bacterial proteins.
    Ikeda T; Uchiyama I; Iwasaki M; Sasaki T; Nakagawa M; Okita K; Masui S
    Genes Cells; 2017 Oct; 22(10):918-928. PubMed ID: 28776863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of Induced Pluripotent Stem Cells from Human Epidermal Melanocytes by Transduction with Two Combinations of Transcription Factors.
    Cheng S; Li D; Zhang RZ; Zhu J; Wang L; Liu Q; Chen RH; Liu XM
    Curr Gene Ther; 2020; 19(6):395-403. PubMed ID: 32072883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells.
    Serrano F; García-Bravo M; Blazquez M; Torres J; Castell JV; Segovia JC; Bort R
    Stem Cell Res Ther; 2016 Jul; 7(1):96. PubMed ID: 27460218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes.
    Worringer KA; Rand TA; Hayashi Y; Sami S; Takahashi K; Tanabe K; Narita M; Srivastava D; Yamanaka S
    Cell Stem Cell; 2014 Jan; 14(1):40-52. PubMed ID: 24239284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation of Reprogramming Intermediates During Generation of Induced Pluripotent Stem Cells from Mouse Embryonic Fibroblasts.
    Nefzger CM; Alaei S; Polo JM
    Methods Mol Biol; 2015; 1330():205-18. PubMed ID: 26621600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reprogramming bladder cancer cells for studying cancer initiation and progression.
    Iskender B; Izgi K; Canatan H
    Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Derivation of LIF-independent mouse iPS cells with modified Oct4.
    Hirai H; Firpo M; Kikyo N
    Stem Cell Res; 2015 Sep; 15(2):384-6. PubMed ID: 26318720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptome Signature and Regulation in Human Somatic Cell Reprogramming.
    Tanaka Y; Hysolli E; Su J; Xiang Y; Kim KY; Zhong M; Li Y; Heydari K; Euskirchen G; Snyder MP; Pan X; Weissman SM; Park IH
    Stem Cell Reports; 2015 Jun; 4(6):1125-39. PubMed ID: 26004630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
    Lee HK; Morin P; Wells J; Hanlon EB; Xia W
    Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.
    Wang AYL; Loh CYY
    Cell Transplant; 2019 Dec; 28(1_suppl):112S-131S. PubMed ID: 31722555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.